FDA Approves At-Home Starting Dose for Lecanemab - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

  • By

  • Kathryn Wighton

  • July 13, 2026

  • 3 min

Share

Original Source(s)

FDA Approves At-Home Starting Dose for Lecanemab

  • by Kathryn Wighton

  • July 13, 2026

Related Content

Activity, Sleep Tied to Dementia Risk

Meta-analysis links higher activity, less sitting, and 7 to 8 hours of sleep with lower incident dementia risk, though findings vary widely across studies.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Side Effects: Sour Mouth, Lower BP

Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.